![Teva completes $703M sale of women's health products to CVC Capital Partners. - Philadelphia Business Journal Teva completes $703M sale of women's health products to CVC Capital Partners. - Philadelphia Business Journal](https://media.bizj.us/view/img/2625011/doctor-patient-consult*1200xx1414-1414-354-0.jpg)
Teva completes $703M sale of women's health products to CVC Capital Partners. - Philadelphia Business Journal
![Pen insulin Ovaleap Kinderwunsch NEU / Unifine Pentips Pennadeln Diabetes, € 10,- (1210 Wien) - willhaben Pen insulin Ovaleap Kinderwunsch NEU / Unifine Pentips Pennadeln Diabetes, € 10,- (1210 Wien) - willhaben](https://cache.willhaben.at/mmo/5/690/158/145_1500707791.jpg)
Pen insulin Ovaleap Kinderwunsch NEU / Unifine Pentips Pennadeln Diabetes, € 10,- (1210 Wien) - willhaben
Company Update (NYSE:TEVA): Teva Pharmaceutical Industries Ltd (ADR) Sells Off Last of Specialty Global Women's Health Portfolio Assets in $1.38 Billion Deal
![OVALEAP (follitropine alfa) : nouveau biosimilaire de GONALF dans la prise en charge de l'infertilité OVALEAP (follitropine alfa) : nouveau biosimilaire de GONALF dans la prise en charge de l'infertilité](https://vidalactus.vidal.fr/files/uploads/actus/images/OVALEAP_GONAL_F_follitropine-alfa_infertilite_anovulation_superovulation_assistance_medical_procreation_spermatogenese_hypogonadisme_hypogonadotrophique_biosimilaire_TEVAsante.jpg)
OVALEAP (follitropine alfa) : nouveau biosimilaire de GONALF dans la prise en charge de l'infertilité
![Plastics World on Twitter: "Owen Mumford launches Ovaleap self-injectable pen for Teva's new fertility treatment https://t.co/Llisz6PSy9 https://t.co/0xaL3coIrP" / Twitter Plastics World on Twitter: "Owen Mumford launches Ovaleap self-injectable pen for Teva's new fertility treatment https://t.co/Llisz6PSy9 https://t.co/0xaL3coIrP" / Twitter](https://pbs.twimg.com/media/CmMNtX8WAAAn80I.jpg:large)
Plastics World on Twitter: "Owen Mumford launches Ovaleap self-injectable pen for Teva's new fertility treatment https://t.co/Llisz6PSy9 https://t.co/0xaL3coIrP" / Twitter
![PDF) Manufacturing of Recombinant Human Follicle-Stimulating Hormone Ovaleap(®) (XM17), Comparability with Gonal-f(®), and Performance/Consistency PDF) Manufacturing of Recombinant Human Follicle-Stimulating Hormone Ovaleap(®) (XM17), Comparability with Gonal-f(®), and Performance/Consistency](https://i1.rgstatic.net/publication/315827471_Manufacturing_of_Recombinant_Human_Follicle-Stimulating_Hormone_OvaleapR_XM17_Comparability_with_Gonal-fR_and_PerformanceConsistency/links/58ed3090aca2724f0a26c1c8/largepreview.png)
PDF) Manufacturing of Recombinant Human Follicle-Stimulating Hormone Ovaleap(®) (XM17), Comparability with Gonal-f(®), and Performance/Consistency
![Teva completes $703M sale of women's health products to CVC Capital Partners. - Philadelphia Business Journal Teva completes $703M sale of women's health products to CVC Capital Partners. - Philadelphia Business Journal](https://media.bizj.us/view/img/10777492/47002105ovaleap300ie-0-5ml*660xx640-360-0-60.jpg)